Press Releases from Reinnervate (3 total)
Reinnervate to present and exhibit at the American Society for Cell Biology annu …
Reinnervate, the expert in making routine 3D cell culture a reality, has announced that the company will exhibit and present at this year’s American Society for Cell Biology (ASCB) annual conference (Denver, USA, 3 – 7th December 2011). Reinnervate’s Chief Scientific Officer, Professor Stefan Przyborski, will deliver a case study presentation at 18.15 on Sunday 4th December entitled ‘Enabling Routine 3D Cell Culture for Disease Modelling, Toxicity Screening and Safety…
Reinnervate and Mirus Bio announce collaboration with the launch of the new 3D T …
Reinnervate (Sedgefield, UK) and Mirus Bio (Madison, USA) today announced a commercial agreement to launch a new range of products for the transfection of cells cultured in 3D.
Under the agreement, Mirus will produce and sell kits combining TransIT®-3D Transfection Reagent, alvetex® 3D cell culture plates and detailed protocols for achieving transfection of selected cell lines growing in 3D.
The kits will enable scientists to evaluate the growth of cells in 3D,…
REINNERVATE EXPANDS ITS DISTRIBUTION NETWORK FOR ALVETEX® ACROSS EUROPE
Reinnervate, the emerging global leader in the rapidly growing 3D cell culture market, is delighted to announce it has signed agreements with seven new European distributors for the non-exclusive distribution of alvetex®, its breakthrough 3D cell culture technology.
These agreements mark a significant expansion of reinnervate’s distribution network. Under the terms of the new agreements, alvetex® will be distributed and sold under the reinnervate brand by leading regional distributors of life…
